Patent classifications
C07H23/00
PRECIPITATION PROMOTER AND PRECIPITATION METHOD IN WHICH SAME IS USED
Precipitation promoters, which are an organic compound having one or more linear aliphatic hydrocarbon groups having not less than 10 carbon atoms, wherein the aliphatic hydrocarbon group has not less than 20 carbon atoms in total are useful for precipitating an organic compound protected by an organic group having one or more aliphatic hydrocarbon groups having not less than 10 carbon atoms from a solvent.
PRECIPITATION PROMOTER AND PRECIPITATION METHOD IN WHICH SAME IS USED
Precipitation promoters, which are an organic compound having one or more linear aliphatic hydrocarbon groups having not less than 10 carbon atoms, wherein the aliphatic hydrocarbon group has not less than 20 carbon atoms in total are useful for precipitating an organic compound protected by an organic group having one or more aliphatic hydrocarbon groups having not less than 10 carbon atoms from a solvent.
Ultrastable silver nanoparticles
Ultrastable silver nanoparticles, methods of making the same, and methods of using the same, are disclosed.
Ultrastable silver nanoparticles
Ultrastable silver nanoparticles, methods of making the same, and methods of using the same, are disclosed.
IRON COMPLEX COMPOUNDS FOR THERAPUTIC USE
The present invention relates to iron complex compounds for therapeutic use which are low in arsenic, chromium, lead, cadmium, mercury and/or aluminum, compositions thereof and processes for preparing said iron complex compounds.
IRON COMPLEX COMPOUNDS FOR THERAPUTIC USE
The present invention relates to iron complex compounds for therapeutic use which are low in arsenic, chromium, lead, cadmium, mercury and/or aluminum, compositions thereof and processes for preparing said iron complex compounds.
3' PROTECTED NUCLEOTIDES
The present disclosure provides 3′ protected nucleotides, including those 3′ protected nucleotides having a detectable tag. Systems and methods of sequencing nucleic acids using the 3′ protected nucleotides are also disclosed, such as the sequencing of a nucleic acid using a nanopore or the sequencing of a nucleic acid via sequencing-by-synthesis.
Transcriptome In Vivo Analysis (TIVA) and Transcriptome In Situ Analysis (TISA)
Compositions and methods of capturing one or more nucleic acid molecules of a cell or subcellular compartment are described. In certain aspects, the compositions comprise a caged molecule comprising one or more photolinkers and an antisense oligonucleotide, which when uncaged hybridizes to a target nucleic acid molecule.
Transcriptome In Vivo Analysis (TIVA) and Transcriptome In Situ Analysis (TISA)
Compositions and methods of capturing one or more nucleic acid molecules of a cell or subcellular compartment are described. In certain aspects, the compositions comprise a caged molecule comprising one or more photolinkers and an antisense oligonucleotide, which when uncaged hybridizes to a target nucleic acid molecule.
Multi-Fluorous Blockmer for Oligonucleotide Synthesis, and Oligonucleotide Synthesis Method Using the Same
Provided are a multi-fluorous blockmer using a readily available fluorous tag and capable of reducing burdens of purification, and an oligonucleotide synthesis method using the same. A multi-fluorous blockmer represented by the formula is synthesized: wherein B is a natural or modified nucleobase; R.sup.1 is a protecting group that can be removed for deprotection under acidic or neutral conditions; R.sup.3 is a protecting group for phosphate; Pro is unprotected, protected, or F-protector, wherein F-protector is O(CH.sub.2).sub.n(CF.sub.2).sub.mCF.sub.3 when the protected moiety of nucleoside base B is O, and is NH(C═O) (CH.sub.2).sub.n(CF.sub.2).sub.mCF.sub.3 when the protected moiety of nucleoside base B is N, wherein n is 1 or 2 and m is an integer of 1 to 20; X is O or S; l is an integer of 0 to 58; R.sup.7 is (C═O) (CH.sub.2).sub.2(C═O) (CH.sub.2).sub.n(CF.sub.2).sub.mCF.sub.3 or a silyl protecting group, wherein n is 1 or 2 and m is an integer of 1 to 20.
##STR00001##